معرفی
J. Todd Arnedt, Ph.D., is a Professor in the Department of Psychiatry at the University of Michigan Medical School. He serves as Co-Director of the Sleep and Circadian Research Laboratory and Director of the Behavioral Sleep Medicine Program. His expertise lies in behavioral sleep medicine, particularly addressing sleep disorders in individuals with substance use disorders. Dr. Arnedt’s research focuses on cognitive-behavioral interventions for insomnia, sleep-alcohol interactions, and occupational sleepiness.
Dr. Arnedt holds a Ph.D. in Clinical Psychology (2000), M.A. in Clinical Psychology (1994), and B.A. in Psychology (1991) from Queen’s University. His work bridges clinical practice and research, emphasizing evidence-based treatments for insomnia and substance-related sleep disturbances.
Key research themes include:
- Cognitive-behavioral therapy (CBT) for insomnia in alcohol use disorder (AUD) and cannabis dependence
- Efficacy of telemedicine-delivered CBT-I for AUD patients
- Circadian rhythm interventions (e.g., melatonin use)
- Sleep’s role in relapse prevention and harm reduction
His articles highlight the bidirectional relationship between sleep and substance use, with a focus on improving outcomes through targeted behavioral therapies. He has contributed to clinical guidelines for insomnia treatment and explored pandemic-related sleep disruptions among healthcare workers.
Dr. Arnedt’s affiliations include leadership in sleep research labs and programs, emphasizing translational research to clinical practice. He collaborates on grants addressing sleep interventions in vulnerable populations and has led randomized controlled trials to validate CBT-I protocols.
